A detailed history of All Terrain Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, All Terrain Financial Advisors, LLC holds 5,606 shares of BMY stock, worth $332,267. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,606
Previous 5,606 -0.0%
Holding current value
$332,267
Previous $232,000 25.0%
% of portfolio
0.11%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $56,712 - $64,300
-1,182 Reduced 17.41%
5,606 $304,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $23,597 - $27,508
-440 Reduced 6.09%
6,788 $423,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $35,041 - $38,159
-566 Reduced 7.26%
7,228 $483,000
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $17,802 - $20,022
-300 Reduced 3.71%
7,794 $492,000
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $57,430 - $63,640
1,000 Added 14.1%
8,094 $488,000
Q2 2020

Jul 28, 2020

BUY
$54.82 - $64.09 $54,820 - $64,090
1,000 Added 16.41%
7,094 $417,000
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $68,943 - $89,930
1,401 Added 29.85%
6,094 $391,000
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $44,822 - $53,144
-1,048 Reduced 18.25%
4,693 $238,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $5,845 - $6,463
-131 Reduced 2.23%
5,741 $260,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $22,560 - $26,900
500 Added 9.31%
5,872 $280,000
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $12,921 - $16,755
-265 Reduced 4.7%
5,372 $279,000
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $118,492 - $133,650
-2,147 Reduced 27.58%
5,637 $350,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $40,727 - $50,761
806 Added 11.55%
7,784 $431,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $59,920 - $68,980
-1,000 Reduced 12.53%
6,978 $441,000
Q4 2017

Feb 15, 2018

BUY
$59.94 - $65.35 $478,201 - $521,362
7,978
7,978 $489,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track All Terrain Financial Advisors, LLC Portfolio

Follow All Terrain Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.